2Savelli L,Iaco PD,Santini D,et al.Histopathologic features and risk factors for benignity,hyperplasia,and cancer in endometrial polyps[J].J Am Assoc Gynecol Laparosc,2003,188(4):927-931.
3Bouda JJ,Hradecky L,Rokyta Z.Hysteroscopic polypectomy versus fractionated curettage in the treatment of corporal polyps-recurrence of corporal polyps[J]. Ceska Gynekol,2000,65(3):147-151.
4Hachisuga T,Miyakawa T,Tsujioka H,et al.K-ras mutation in tamoxifen-related endometrial polyps[J].Cancer,2003,98(9):1890-1897.